The rising interest in potent weight management has spurred considerable research into novel treatments. Recently , Retatrutide, a twin-action GIP and glucagon-like peptide-1 (GLP-1) receptor stimulator, has exhibited promising results in clinical trials, indicating potential for substantial weight reduction . Therefore, several individuals are loo